Researchers who opt to administer GHK-Cu via injection should note that most side effects observed, including nausea and redness/pain at injection site, more commonly result from the injections than the peptide itself
The topical application concentrates active compound at follicle sites while injections support overall regenerative processes
The dosing below draws from the per-component research and is reflected in the FDA review committee documents for each peptide, which aligns with PeptideFoxs previous research
The fluid retention can also increase blood pressure and stress the cardiovascular system
If you experience persistent pain, spreading redness, warmth, or discharge from an injection site, seek medical attention
Researchers interested in peptide purity testing, HPLC peptide analysis, LC-MS verification, laboratory handling, storage recommendations, and peptide quality control can browse our Research Peptide Guides